CAS: 1421373-65-0 AZD-9291
CAS Nr.: 1421373-65-0
Purity: 97% Min.
Pob: 5g / 25g / 100g
Kev xa khoom: DHL / FEDEX / UPS lossis Los ntawm hiav txwv
- Kev xa khoom thoob ntiaj teb
- Quality Assurance
- 24/7 Kev Pabcuam Cov Neeg Siv Khoom
Khoom Taw qhia
Taw qhia
Osimertinib (yav tas los hu ua mereletinib lossis AZD9291; lub npe lag luam Tagrisso) yog lub thib peb tiam epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) tshuaj tsim los ntawm AstraZeneca Pharmaceuticals - rau mutated EGFR qog noj ntshav.
Specification ntawm CAS: 1421373-65-0 AZD-9291
Yam khoom | SPECIFICATION |
CAS DataBase Reference | 1421373-65-0 |
pka ua | 12.68 ± 0.70 (Tshaj tawm) |
ceev | 1.19 ± 0.1 g / cm3 (Tshaj tawm) |
Related articles ntawmCAS: 1421373-65-0 AZD-9291
SHR-A1403, ib qho tshiab c-mesenchymal-epithelial kev hloov pauv hloov pauv (c-Met) antibody-drug conjugate, kov yeej AZD 9291 tsis kam nyob rau hauv cov qog nqaij hlav tsis me me hauv lub ntsws ...
M Tong, M Gao, Y Xu, L Fu, Y Li, X Bao, H Fu... - Cancer ..., 2019 - Wiley Online Library
Cov ntaub ntawv qhia txog tshuaj lom epidermal necrolysis txuam nrog AZD-9291
J Wang, XY Cheng, Y Lu, BR Zhou - Drug Design, Development …, 2018 - ncbi.nlm.nih.gov
Cim npe nrov: cas: 1421373-65-0 azd-9291, nqe, hais, luv nqi, hauv Tshuag, muag
